UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

The New England journal of medicine, 2018-05, Vol.378 (19), p.1789-1801

2018

Volltextzugriff (PDF)

Gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol

BMC cancer, 2017-04, Vol.17 (1), p.258-258, Article 258

2017

Volltextzugriff (PDF)

Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients

European journal of cancer (1990), 2014-09, Vol.50 (13), p.2280-2288

2014

Volltextzugriff (PDF)

Ultrasound Morphology Criteria Predict Metastatic Disease of the Sentinel Nodes in Patients With Melanoma

Journal of clinical oncology, 2010-02, Vol.28 (5), p.847-852

2010

Volltextzugriff (PDF)

Melanoma

The Lancet (British edition), 2018-09, Vol.392 (10151), p.971-984

2018

Volltextzugriff (PDF)

Importance of tumor load in the sentinel node in melanoma: clinical dilemmas

Nature reviews. Clinical oncology, 2010-08, Vol.7 (8), p.446-454

2010

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

European journal of cancer (1990), 2022-07, Vol.170, p.256-284

2022

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

European journal of cancer (1990), 2022-07, Vol.170, p.236-255

2022

Volltextzugriff (PDF)

Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma

European journal of cancer (1990), 2023-03, Vol.182, p.38-42

2023

Volltextzugriff (PDF)

Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma

European journal of cancer (1990), 2023-03, Vol.182, p.163-169

2023

Volltextzugriff (PDF)

Impact of Molecular Staging Methods in Primary Melanoma: Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) of Ultrasound-Guided Aspirate of the Sentinel Node Does Not Improve Diagnostic Accuracy, But RT-PCR of Peripheral Blood Does Predict Survival

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5742-5747

2008

Volltextzugriff (PDF)

The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes

Journal of clinical pathology, 2024-06, Vol.77 (6), p.372-377

2024

Volltextzugriff (PDF)

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

European journal of cancer (1990), 2023-05, Vol.185, p.131-138

2023

Volltextzugriff (PDF)

The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients – A Potential Paradigm Shift in Management

Annals of surgical oncology, 2020-07, Vol.27 (7), p.2188-2200

2020

Volltextzugriff (PDF)

Sentinel Node Biopsy in Melanoma: current controversies addressed

European journal of surgical oncology, 2017-03, Vol.43 (3), p.517-533

2017

Volltextzugriff (PDF)

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

European journal of cancer (1990), 2023-08, Vol.189, p.112900-112900, Article 112900

2023

Volltextzugriff (PDF)

The use of FDG‐PET/CT to detect early recurrence after resection of high‐risk stage III melanoma

Journal of surgical oncology, 2020-12, Vol.122 (7), p.1328-1336

2020

Volltextzugriff (PDF)

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma

Annals of surgical oncology, 2023-08, Vol.30 (8), p.5017-5026

2023

Volltextzugriff (PDF)

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

European journal of cancer (1990), 2024-04, Vol.201, p.113585-113585, Article 113585

2024

Volltextzugriff (PDF)

Postoperative radiotherapy in stage I–III Merkel cell carcinoma

Radiotherapy and oncology, 2022-01, Vol.166, p.203-211

2022

Volltextzugriff (PDF)

Challenges in sentinel node pathology in the era of adjuvant treatment

Journal of surgical oncology, 2020-10, Vol.122 (5), p.964-972

2020

Volltextzugriff (PDF)

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

Melanoma research, 2020-04, Vol.30 (2), p.185-192

2020

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaNeoplasm Staging

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol

Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients

Ultrasound Morphology Criteria Predict Metastatic Disease of the Sentinel Nodes in Patients With Melanoma

Melanoma

Importance of tumor load in the sentinel node in melanoma: clinical dilemmas

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma

Impact of Molecular Staging Methods in Primary Melanoma: Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) of Ultrasound-Guided Aspirate of the Sentinel Node Does Not Improve Diagnostic Accuracy, But RT-PCR of Peripheral Blood Does Predict Survival

Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma

The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients – A Potential Paradigm Shift in Management

Sentinel Node Biopsy in Melanoma: current controversies addressed

Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

The use of FDG‐PET/CT to detect early recurrence after resection of high‐risk stage III melanoma

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Postoperative radiotherapy in stage I–III Merkel cell carcinoma

Challenges in sentinel node pathology in the era of adjuvant treatment

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

Aktive Filter

Suchergebnisse filtern